ISB Has Two New Patents

Science Transforming Health

ISB News

ISB Has Two New Patents

isbscience.org/news/2014/02/04/isb-has-two-new-patents/
 Posted on February 4, 2014

2014 is off to a great start for innovation in human health. ISB released two new patents in January that will make great contributions to personalized medicine. One of the patents, issued on January 27 and titled Use of Gene Expression Signatures to Determine Cancer Grade, has ISB President Dr. Lee Hood and ISB Senior Research Scientist Qiang Tian listed as inventors. Also sharing in that patent is Xiaowei Yan and the late Gregory Foltz. Read more about the patent here.

The second patent, released January 21, details New Biomarkers for Liver Injury. Sharing this patent are inventors Zhiyuan Hu; ISB Senior Research Engineer, Chris Lausted; and ISB President Dr. Lee Hood. Read more about this fascinating patent here.

And just as a reminder, if you do ever want to peruse all of ISB's US Patents with convenient links out to the US Government's official description of the patent, please visit https://www.isbscience.org/patents

 Category: Dr. Lee Hood, ISB News, Slider

 Tags:, , , , , ,

Recent Articles

  • Spotlight on ISB Education graphic

    2023-24 School Year ISB Education Highlights

     Posted on April 2, 2024

    Each month throughout the 2023-2024 academic year, we will highlight some of the top projects the ISB Education team is working on. In March, ISB Education highlights include a paper published in a Nature Portfolio journal, two events for science/STEM leaders, and more.

  • STEM Program Models for Students from Historically Marginalized Communities

     Posted on March 7, 2024

    A new study unveils important insights and actionable protocols into providing equitable STEM experiences for high school students from historically marginalized communities. The research highlights the transformative power of informal STEM learning and the ease with which many organizations could provide these opportunities.

  • Common Immune Response Protective Across Many Diseases

     Posted on March 4, 2024

    Infection, autoimmunity and cancer account for 40 percent of deaths worldwide. In a Cell Reports paper, ISB researchers detail how the human immune system works in common ways across diseases – findings that offer promising avenues for exploring multi-disease therapeutic strategies.

Sitemap

Institute for Systems Biology is a nonprofit scientific research organization located in Seattle © 2024 · All Rights Reserved · Institute for Systems Biology

RSS Feed · Log in